Bulletin
Investor Alert

New York Markets Open in:

Moderna Inc.

NAS: MRNA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 5, 2021, 7:59 p.m.

/zigman2/quotes/205619834/composite

$

164.60

Change

+1.76 +1.08%

Volume

Volume 682,750

Quotes are delayed by 20 min

/zigman2/quotes/205619834/composite

Previous close

$ 173.59

$ 162.84

Change

-10.75 -6.19%

Day low

Day high

$156.81

$180.70

Open

52 week low

52 week high

$46.13

$189.26

Open

Annual Financials for Moderna Inc.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue 108.4M205.83M135.07M60.21M803.4M
Cost of Goods Sold (COGS) incl. D&A ----39.18M
COGS excluding D&A ----7.93M
Depreciation & Amortization Expense 15.11M20.54M24.86M31.02M31.25M
Depreciation 15.11M20.54M24.86M31.02M31.25M
Amortization of Intangibles -----
Gross Income ----764.21M
20162017201820192020 5-year trend
SG&A Expense 317.05M454.64M579.07M574.91M1.53B
Research & Development 274.72M410.46M509.68M465.29M1.34B
Other SG&A 42.34M44.19M69.39M109.62M188.27M
Other Operating Expense -----
Unusual Expense ----1.6M
EBIT after Unusual Expense ----(764.74M)
Non Operating Income/Expense (2.71M)(1.74M)4.93M(914,000)5.4M
Non-Operating Interest Income 11.31M15.24M27.02M38.53M24.72M
Equity in Affiliates (Pretax) -----
Interest Expense -132,0003.1M6.61M9.89M
Gross Interest Expense -132,0003.1M6.61M9.89M
Interest Capitalized -----
Pretax Income (215.17M)(256M)(440.01M)(514.72M)(744.51M)
Income Tax 1.04M(80,000)(55.27M)(695,000)2.55M
Income Tax - Current Domestic 755,000(80,000)326,000505,00032,000
Income Tax - Current Foreign ----2.52M
Income Tax - Deferred Domestic 288,000--(1.2M)-
Income Tax - Deferred Foreign -----
Income Tax Credits --55.6M--
Equity in Affiliates -----
Other After Tax Income (Expense) --(4.13M)--
Consolidated Net Income (216.21M)(255.92M)(388.86M)(514.02M)(747.06M)
Minority Interest Expense -----
Net Income (216.21M)(255.92M)(388.86M)(514.02M)(747.06M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (216.21M)(255.92M)(388.86M)(514.02M)(747.06M)
Preferred Dividends 14.1M13.93M13M--
Net Income Available to Common (230.31M)(269.84M)(401.86M)(514.02M)(747.06M)
EPS (Basic) (0.69)(1.92)(4.95)(1.55)(1.96)
Basic Shares Outstanding 332.89M140.6M81.11M330.8M381.33M
EPS (Diluted) (0.69)(1.92)(4.95)(1.55)(1.96)
Diluted Shares Outstanding 332.89M140.6M81.11M330.8M381.33M
EBITDA (208.66M)(248.82M)(444M)(514.7M)(731.89M)
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.